News

WTHI News102h
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The FDA appears poised to continue with a plan to ban prescription fluoride supplements at a time when many experts say that access to the products has become especially important.
RFK Jr. Taps Drug Chief From Revolving Door He Vowed to Close
The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
FDA picks George Tidmarsh to head Center for Drug Evaluation and Research
The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug ...
The FDA Might Ban Fluoride Supplements. Dentists Are Upset
D r. James H. Bekker made it clear while standing at a podium in front of the U.S. Food and Drug Administration (FDA) in ...
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
Pharma exec to lead FDA drug unit
The FDA has named Dr. George Tidmarsh to lead its drug division, putting him at the helm of the agency’s drug approval ...
FDA names former pharmaceutical company executive to oversee US drug program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
Healio4d
FDA names Stanford professor Tidmarsh director of Center for Drug Evaluation and Research
The FDA appointed George F. Tidmarsh, MD, PhD, the director of the Center for Drug Evaluation and Research, the agency announced on Monday.Tidmarsh, an adjunct professor of pediatrics and neonatology ...
STAT4d
New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
Biotech exec George Tidmarsh picked as FDA's chief drug regulator
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
Former biotech executive appointed to lead FDA drug office
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...